Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries' financial results presentation for the fourth quarter and full year 2022, delivered February 8, 2023. The presentation includes discussion of the company's generic pharmaceuticals portfolio, branded products including AUSTEDO, AJOVY, and COPAXONE, along with risk factors and forward-looking guidance.
earnings
37 Pages
earnings
45 Pages
Credit Suisse
MDU Resources Q1 2023 Earnings Call Presentation
earningsearnings
21 Pages
MDU Resources Group, Inc.
J.B. Hunt Q2 2020 Earnings Results
earningsearnings
20 Pages
J.B. Hunt Transport Services
AIA Engineering Q4 FY2022 Earnings Presentation
earningsearnings
9 Pages
AIA Engineering Limited